Hear the Patient's Voice Regarding Implementation of Thyroid Cancer Active Surveillance in China

ThyroidVol. 33, No. 7 CommentariesHear the Patient's Voice Regarding Implementation of Thyroid Cancer Active Surveillance in ChinaZhuoying Wang and Haixia GuanZhuoying WangDepartment of Head and Neck Surgery, Renji Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, P.R. China.Search for more papers by this author and Haixia GuanAddress correspondence to: Haixia Guan, MD, PhD, Department of Endocrinology, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, 106 Zhongshan Er Road, Guangzhou 510080, P.R. China E-mail Address: [email protected]https://orcid.org/0000-0003-3155-2847Department of Endocrinology, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, P.R. China.Search for more papers by this authorPublished Online:13 Jul 2023https://doi.org/10.1089/thy.2023.0058AboutSectionsView articleView Full TextPDF/EPUB Permissions & CitationsPermissionsDownload CitationsTrack CitationsAdd to favorites Back To Publication ShareShare onFacebookTwitterLinked InRedditEmail View articleFiguresReferencesRelatedDetails Volume 33Issue 7Jul 2023 InformationCopyright 2023, Mary Ann Liebert, Inc., publishersTo cite this article:Zhuoying Wang and Haixia Guan.Hear the Patient's Voice Regarding Implementation of Thyroid Cancer Active Surveillance in China.Thyroid®.Jul 2023.782-784.http://doi.org/10.1089/thy.2023.0058Published in Volume: 33 Issue 7: July 13, 2023Online Ahead of Print:March 17, 2023Online Ahead of Editing: February 15, 2023PDF download